IAG Cargo has recently reported a significant 22% year-over-year increase in tonnage for its Constant Climate product in 2024, underscoring the growing demand for temperature-controlled air freight in the pharmaceutical industry. This specialized service is specifically designed to transport critical medical products such as vaccines, biotech materials, and diagnostic samples, playing a vital role in the pharmaceutical supply chain. Notably, nearly half of these shipments originated from key markets like India and Ireland, both of which have experienced substantial growth in pharmaceutical exports.
Jordan Kohlbeck, the Head of Pharmaceutical at IAG Cargo, emphasized the critical importance of secure and temperature-controlled logistics in ensuring the safe and efficient delivery of life-saving medicines and treatments to patients. He highlighted the company’s ongoing investments in facilities and workforce to meet the increasing demand for such specialized services.
Recent industry data further supports this trend, with Ireland’s medical and pharmaceutical exports witnessing a significant €2.9 billion increase (+48%) in January 2024 compared to the previous year, constituting nearly half of the country’s total exports. Similarly, India’s drug and pharma exports also saw a notable rise from $2.13 billion in 2023 to $2.31 billion in 2024, accounting for a substantial 20% share of the global pharmaceutical supply chain.
In response to this growing demand, IAG Cargo has expanded its Constant Climate network by adding approved stations in key locations such as Cincinnati, Cape Town, and Strasbourg. Furthermore, the opening of the state-of-the-art New Premia facility at London Heathrow has effectively doubled the company’s cool chain storage and handling capacity, solidifying its position as a leading player in pharmaceutical logistics.
As the global demand for pharmaceutical products continues to accelerate, IAG Cargo remains steadfast in its commitment to providing reliable and temperature-controlled solutions to ensure that life-saving medicines reach patients safely and efficiently. The company’s focus on enhancing its capabilities and expanding its network underscores its dedication to meeting the evolving needs of the pharmaceutical industry and delivering exceptional service to its customers.
In conclusion, the significant increase in tonnage for IAG Cargo’s Constant Climate product reflects the growing importance of temperature-controlled air freight in the pharmaceutical sector. With a strong emphasis on secure and reliable logistics, coupled with strategic investments in facilities and workforce, IAG Cargo is well-positioned to meet the rising demand for specialized pharmaceutical transportation services. By expanding its network and enhancing its capabilities, the company continues to play a crucial role in ensuring the safe and efficient delivery of critical medical products to patients around the world.
